IL157304A0 - Method of extracting virus from cell culture - Google Patents

Method of extracting virus from cell culture

Info

Publication number
IL157304A0
IL157304A0 IL15730402A IL15730402A IL157304A0 IL 157304 A0 IL157304 A0 IL 157304A0 IL 15730402 A IL15730402 A IL 15730402A IL 15730402 A IL15730402 A IL 15730402A IL 157304 A0 IL157304 A0 IL 157304A0
Authority
IL
Israel
Prior art keywords
cell culture
extracting virus
virus
extracting
culture
Prior art date
Application number
IL15730402A
Other languages
English (en)
Original Assignee
Oncolytics Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncolytics Biotech Inc filed Critical Oncolytics Biotech Inc
Publication of IL157304A0 publication Critical patent/IL157304A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A61K35/765—Reovirus; Rotavirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12211—Orthoreovirus, e.g. mammalian orthoreovirus
    • C12N2720/12232—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12211—Orthoreovirus, e.g. mammalian orthoreovirus
    • C12N2720/12251—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL15730402A 2001-03-16 2002-03-11 Method of extracting virus from cell culture IL157304A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27673401P 2001-03-16 2001-03-16
PCT/CA2002/000331 WO2002074940A1 (en) 2001-03-16 2002-03-11 Method of extracting virus from cell culture

Publications (1)

Publication Number Publication Date
IL157304A0 true IL157304A0 (en) 2004-02-19

Family

ID=29420186

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15730402A IL157304A0 (en) 2001-03-16 2002-03-11 Method of extracting virus from cell culture
IL157304A IL157304A (en) 2001-03-16 2003-08-07 Method for extracting viral virus from cell culture 293 HEK

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL157304A IL157304A (en) 2001-03-16 2003-08-07 Method for extracting viral virus from cell culture 293 HEK

Country Status (14)

Country Link
US (2) US6808916B2 (xx)
EP (2) EP1370643A1 (xx)
JP (2) JP4087712B2 (xx)
AR (1) AR034216A1 (xx)
BR (1) BR0207527A (xx)
CA (1) CA2437962C (xx)
DK (1) DK2253701T3 (xx)
ES (1) ES2500645T3 (xx)
HK (1) HK1150859A1 (xx)
IL (2) IL157304A0 (xx)
MX (1) MXPA03007535A (xx)
NZ (1) NZ527525A (xx)
WO (1) WO2002074940A1 (xx)
ZA (1) ZA200306228B (xx)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1501921T4 (da) 2002-04-30 2012-10-08 Oncolytics Biotech Inc Forbedrede virusrensningsmetoder
EP1634947A4 (en) * 2003-06-10 2007-10-03 Shimadzu Corp EXTRACT FROM A CULTURED MAMMALIAN CELL, PROCESS FOR THEIR PREPARATION AND METHOD FOR CELL-FREE PROTEIN SYNTHESIS USING THE EXTRACT
US7901921B2 (en) 2004-10-22 2011-03-08 Oncolytics Biotech Inc. Viral purification methods
US10260049B2 (en) 2005-08-01 2019-04-16 Virocure, Inc. Attenuated reovirus
US10668119B2 (en) 2005-08-01 2020-06-02 Virocure, Inc. Attenuated reovirus
EP2952583A1 (en) 2007-03-12 2015-12-09 Oncolytics Biotech Inc. Reoviruses having modified sequences
US10369171B2 (en) 2007-03-13 2019-08-06 Virocure, Inc. Attenuated reoviruses for selection of cell populations
AR066649A1 (es) * 2007-05-21 2009-09-02 Oncolytics Biotech Inc Reovirus mutantes y metodos de elaboracion y uso de los mismos
EP2211880A4 (en) * 2007-10-22 2012-11-14 Oncolytics Biotech Inc TREATMENT PROCEDURE FOR PROLIFERATIVE DISEASES
CN201163385Y (zh) * 2008-01-15 2008-12-10 昆山渝榕电子有限公司 笔记本电脑及其脚垫
JP2011520994A (ja) * 2008-05-27 2011-07-21 オンコリティクス バイオテク，インコーポレーテッド 腫瘍崩解性レオウイルス療法中の炎症性サイトカイン産生の排除
MX339014B (es) * 2008-05-27 2016-05-09 Oncolytics Biotech Inc Modulacion de presion intersticial y suministro y distribucion viral oncolitica.
WO2012075376A2 (en) 2010-12-02 2012-06-07 Oncolytics Biotech Inc. Lyophilized viral formulations
SG190418A1 (en) 2010-12-02 2013-07-31 Oncolytics Biotech Inc Liquid viral formulations
CA2832367A1 (en) 2011-04-29 2012-11-01 Oncolytics Biotech Inc. Methods of purifying viruses using gel permeation chromatography
KR102186997B1 (ko) * 2013-03-15 2020-12-07 안선 바이오파르마, 아이엔씨. 단백질 정제의 신규한 방법
EP3068411B1 (en) 2013-11-15 2020-03-18 Oncolytics Biotech Inc. Oncolytic viruses and increased cancer treatment regimens
US10280199B2 (en) 2014-02-07 2019-05-07 Phibro Animal Health Corporation Coronavirus proteins and antigens
WO2016130569A1 (en) * 2015-02-09 2016-08-18 Mj Biologics, Inc. A composition comprising pedv antigens and methods for making and using the composition
DK3172317T3 (da) * 2014-07-24 2019-07-22 Janssen Vaccines & Prevention Bv Fremgangsmåde til oprensning af poliovirus fra cellekulturer
GB201417042D0 (en) * 2014-09-29 2014-11-12 Fkd Therapies Oy Method
WO2023277173A1 (ja) * 2021-06-30 2023-01-05 旭化成メディカル株式会社 ウイルスの回収方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5023252A (en) 1985-12-04 1991-06-11 Conrex Pharmaceutical Corporation Transdermal and trans-membrane delivery of drugs
JPS6344532A (ja) 1986-08-11 1988-02-25 Biseibutsu Kagaku Kenkyusho:Kk 豚のレオウイルス感染症ワクチン
US5614413A (en) * 1993-07-01 1997-03-25 The Uab Research Foundation Encapsidated recombinant poliovirus nucleic acid and methods of making and using same
HRP950097A2 (en) * 1994-03-08 1997-06-30 Merck & Co Inc Hepatitis a virus culture process
US6146873A (en) * 1994-11-10 2000-11-14 Baxter Aktiengesellschaft Production of orthomyxoviruses in monkey kidney cells using protein-free media
EP0968284B1 (en) * 1996-11-20 2006-12-13 Introgen Therapeutics, Inc. An improved method for the production and purification of adenoviral vectors
US6214333B1 (en) * 1997-07-08 2001-04-10 Texas Heart Institute Vasoprotective recombinant adenovirus vector containing a human TFPI gene
US6110461A (en) 1997-08-13 2000-08-29 Oncolytics Biotech Inc. Reovirus for the treatment of neoplasia
TWI289158B (en) 2000-08-10 2007-11-01 Oncolytics Biotech Inc Method of producing infectious reovirus

Also Published As

Publication number Publication date
EP1370643A1 (en) 2003-12-17
ES2500645T3 (es) 2014-09-30
US6808916B2 (en) 2004-10-26
EP2253701B1 (en) 2014-08-13
EP2253701A1 (en) 2010-11-24
US20050095692A1 (en) 2005-05-05
CA2437962A1 (en) 2002-09-26
WO2002074940A1 (en) 2002-09-26
AR034216A1 (es) 2004-02-04
HK1150859A1 (en) 2012-01-13
JP2007295937A (ja) 2007-11-15
JP4087712B2 (ja) 2008-05-21
IL157304A (en) 2010-04-29
ZA200306228B (en) 2004-08-12
NZ527525A (en) 2005-03-24
BR0207527A (pt) 2004-02-25
US7186542B2 (en) 2007-03-06
JP2004520841A (ja) 2004-07-15
CA2437962C (en) 2005-11-15
DK2253701T3 (da) 2014-10-20
US20020168764A1 (en) 2002-11-14
MXPA03007535A (es) 2003-12-11

Similar Documents

Publication Publication Date Title
IL157304A0 (en) Method of extracting virus from cell culture
IL161858A0 (en) Cell culture process
EP1434887A4 (en) METHOD OF ISOLATING CELLS AND USE THEREOF
AU2001234608A1 (en) Methods for analysis of gene expression
IL153906A0 (en) Method for direct genetic analysis of target cells
HUP0500161A3 (en) Methods to culture circovirus
EP1489416A4 (en) METHOD FOR THE EVALUATION OF VIRUS INFECTION
EP1447091A4 (en) NEW METHOD FOR INDUCTION OF ANTIGEN SPECIFIC T CELLS
EP1625832A4 (en) PROCESS FOR REMOVING CELLS
AU2003302701A8 (en) Method of dynamically culturing embryonic stem cells
AU2003232781A1 (en) Method for nucleic acid extraction and nucleic acid purification
IL158927A (en) Method for virus propagation
EP1382673A4 (en) METHOD FOR THE CULTURE OF TAKEN BIOPSY CELLS
EP1394109A4 (en) METHOD FOR SEPARATING ACID
GB0416516D0 (en) Method of transducing es cells
AU2261802A (en) Method of analyzing gene expression
AU2002222618A1 (en) Method of analyzing gene expression
EP1432822A4 (en) METHOD FOR RECOVERING AND ANALYZING A CELLULAR COMPONENT OF CULTIVATED CELLS WITHOUT NEED TO HARVES CELLS FIRST
IL161066A0 (en) Method for preparing heparin from mast cell cultures
AU2003270814A8 (en) Method of extracting nucleic acids from microbial samples
TWI318643B (en) Method of extracting virus from cell culture
EP1378569A4 (en) METHOD FOR EXTRACTING VIRAL GENES AND EXTRACTION APPARATUS
EG25192A (en) Method of extracting iron-oxides.
AU2003208649A1 (en) Method of extracting, isolating and purifying sesame protein
AU2002213695A1 (en) Method of genomic analysis

Legal Events

Date Code Title Description
HC Change of name of proprietor(s)